| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |